R- values 0

R- values 0. 8 were considered as relevant. labeled anti-human-IgG secondary antibodies. To detect changes in autoantibodies spot intensities were digitized and compared. == Results == With respect to the immunoreactivity at 0 weeks level increment of anti-adaptor protein 1 complex subunit mu-1 antibodies and anti-SPRY domain-containing SOCS box protein 3 antibodies in sera of primary open angle patients with optic disc hemorrhage was detected. Linear trend analysis revealed a positive correlation with r 0. 8 between antibody-level and time course. Control group show no relevant changes in the same period. Significant changes were found Octreotide in time point 4 comparison between patient groups Octreotide in anti-adaptor protein 1 complex subunit mu-1-level (p = 0. 01). No significant changes in visual acuity were found. == Conclusion == With this approach we were able to detect autoimmune reactivities in sera of patients with primary open angle glaucoma and optic disc hemorrhage compared to patients without optic disc hemorrhage. These antibodies could give further insights into the pathogenesis and the autoimmune Octreotide component of glaucomatous optic neuropathy. == 1 . Introduction == Glaucoma is the first cause for inalterable visual impairment and irreversible blindness worldwide [1]. In 2040 the number of persons concerned is estimated about 111 million. Glaucoma is a disease of multi-factorial origin with glaucomatous optic neuropathy (GON) and progressive degeneration of retinal ganglion cells (RGC) as major characteristics [2, 3]. Among other glaucoma types primary open angle glaucoma (POAG) is the most common form with a global prevalence of 3% [4, 5]. Elevated intraocular pressure (IOP) is known as the major risk factor and topical pressure lowering therapy is still the first-line treatment in glaucoma disease management. But until now the detailed mechanisms of occurring RGC loss remain unclear [6]. Beside dysfunctional vascular regulation, reactive nitrogen and oxygen species, impaired mitochondria and other factors an autoimmune component is discussed as possible part of glaucoma pathogenesis [711]. Also antibodies (abs) have emerged in the research focus as potential players in GON. In several studies autoabs and complex autoab-profiles could be detected in body fluids of patients with glaucoma compared to healthy subjects [1215]. Furthermore, not only up-regulated, but also down-regulated abs are shown in glaucoma affected individuals [16]. Silent onset, slow and unnoticed progression of visual field narrowing makes diagnosis of the disease challenging in daily clinical routine. Therefore occurring RGC loss and subsequent defects in the optic nerve head are mostly detected when almost 2040% of RGC are irreversible lost [1719]. Irrecoverable visual decay is often the consequence and applied treatment can only slow down or halt pathologic progression. Optimized detection of progression would be strongly beneficial and could ameliorate medical maintenance of patients [20]. This underlines the strong demand for better diagnosis of early glaucoma stages and subsequent structural damage. A widely accepted indication for development and progression of glaucoma is optic disc hemorrhage (ODH). This Octreotide splinter-shaped area of bleeding has found to Rabbit Polyclonal to Chk1 (phospho-Ser296) be associated with the likelihood of disease progression in different large studies and has been considered as an important feature of changes in GON [2126]. To support clinically suspect glaucoma cases an easy to use protein microarray approach with predictive autoabs displaying an upcoming structural worsening could be helpful. Therefore this study aims to analyze autoab-profiles in POAG patients with ODH as a sign of ongoing glaucoma progression in comparison to Octreotide POAG subjects without ODH. The detection of autoabs after ongoing neurodegeneration could give more insight in the role of autoabs in glaucoma pathogenic mechanisms and might help to understand the differences in the enormously complex batch of given autoab reactivities. == 2 . Material and Methods == == 2 . 1 Patients == 16 patients with POAG and ODH and 18 patients with POAG were included in the study and classified in accordance with the guidelines of the European Glaucoma Society (DetailsFig 1A). All participants were subject of a full ophthalmologic examination and treatment at the Department of Ophthalmology, University Medical Center Mainz. Examination, measurement of visual acuity and blood collection time points were directly after study inclusion (0 weeks, time point 1: T1) and after 2 weeks 3 days (time point 2: T2), 4 weeks 7 days.